Ryusaku Kusunoki

Butyric acid attenuates intestinal inflammation in murine DSS-induced colitis model via milk fat globule-EGF factor 8

Tsuyoshi Mishiro, Ryusaku Kusunoki, Aya Otani et al. · Laboratory Investigation · 2013 · 98 citations · Full text

Inflammation, Intestinal Inflammation, Mucosal Immunology +8

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 62 citations · Full text

Placebo-controlled Induction, Gastroenterology, Pathology +6

Role of Regulatory B Cells in Chronic Intestinal Inflammation

Akihiko Oka, Shunji Ishihara, Yoshiyuki Mishima et al. · Inflammatory Bowel Diseases · 2014 · 59 citations · Full text

Inflammation, Chronic Inflammatory Diseases, Autoimmune Disease +13

Fecal Calprotectin More Accurately Predicts Endoscopic Remission of Crohnʼs Disease than Serological Biomarkers Evaluated Using Balloon-assisted Enteroscopy

Kousaku Kawashima, Shunji Ishihara, Takafumi Yuki et al. · Inflammatory Bowel Diseases · 2017 · 58 citations

Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis

Kousaku Kawashima, Shunji Ishihara, Takafumi Yuki et al. · BMC Gastroenterology · 2016 · 57 citations · Full text